AdventHealth partners with Helix for a 10,000-patient DNA sequencing trial
Clinical Leader - 23-Mar-2020A big study to look forward as it intends to improve disease prevention, diagnosis, and management
Join the club for FREE to access the whole archive and other member benefits.
proprietary approach sequencing technology, Helix
Exome+ is Helix' proprietary approach sequencing technology . The “exome” is comprised of all the DNA that encodes for protein—and because proteins are the machinery of your cells, the exome represents some of the most important and well-studied pieces of your DNA. But the exome is only part of your DNA story. The genetic experts at Helix have identified other important information-rich areas to sequence (that’s the “plus” in Exome+).
Visit website: https://blog.helix.com/the-power-of-exome/
See also: Helix - American population genomics company
Details last updated 25-Mar-2020
A big study to look forward as it intends to improve disease prevention, diagnosis, and management